OncoZenge AB's market cap is currently €7.05M. The company's EPS TTM is €-0.020029414; its P/E ratio is ―; OncoZenge AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
